hameln pharma AB
559306-4438ActiveOwner-managed group developing and marketing generic injectable medicines globally.
Pharmaceutical Grouphameln-pharma.com
Yleiskatsaus
- 1–4
- Työntekijät
- 10–20milj SEK
- Liikevaihto
- 2021
- Perustettu
Avainpäättäjät
Beate Küter
CEO
Frank Jahrand
Chief Financial Officer
Stephen Watkin
Chief Commercial Officer
Dr. Uwe Teubert
Chief Quality Officer
+1 lisää yhteystietoja Funnelfeedrissä
Kuvaus
hameln pharma is an internationally operating, fourth-generation owner-managed pharmaceutical group established in 1890. The company specializes in the development, licensing, and marketing of high-quality generic injectable medicines. Their extensive product portfolio primarily serves critical area...